Cordycepin (3'-deoxyadenosine), an inhibitor of poly(A) synthesis during the processing of nuclear heterogenous RNA, blocks the production of RNA viruses induced by 5-iodo-2'-deoxyuridine in BALB/3T3 and BALB/K_3T3 cells. This inhibitory activity is not a result of either nonspecific cell killing or general cytotoxicity by cordycepin; rather, it appears to be specific,because cordycepin acts only at a critical time to inhibit virus production. These findings, together with the finding of poly(A) sequences in viral RNAs, suggest that RNA tumor viruses replicate via a transcription of proviral DNA.
The discovery of RNA-dependent DNA polymerase by Baltimore (1) and by Temin and Mizutani (2) supports the idea that the genetic information of RNA tumor viruses can exist in an infected cell (or transformed cells) in a form of DNA termed a "provirus" (3, 4) . To propagate this genetic information (stored in the provirus), transcription of the proviral DNA into RNA is obviously required. A simple model of viral replication is that the RNA product of transcription can serve as a messenxger for viral-specific protein synthesis, and that this same source of RNA can also be packed into the viral particles where, on further infection, it will serve as a template for RNA-dependent DNA polymerase. Two pieces of information suggest that the 70S RNA of RNA tumor viruses has properties of some cellular mRNA. One-from the work of Siegert et al. (5) -is that AMV RNA can be translated to synthesize virus-specific proteins (group-specific antigens) in a cell-free lysate of Escherichia coli. The otherfrom the work of Lai and Duesberg (6), Gillespie, Marshall, and Gallo (7) , and Green and Cartas (8) -is that the RNA of RNA tumor viruses contains a sequence of poly(A). The size of the poly(A) in the C-type RNA tumor viruses is greater than that found in any nontumor RNA viruses (7) . This latter finding has triggered the hope of that this property can be used as a new footprint for RNA tumor viruses in cells (7) ; more importantly, it has cast some light on the mechanism of viral replication.
The poly(A) sequence was suggested to play an important role in the processing of heterogenous RNA and in the maturation of mRNA, both in cellular mRNA (9) and in the mRNA of DNA viruses (10) . Darnell et al. (9) reported that poly(A) synthesis could be preferentially blocked by cordycepin (3'-deoxyadenosine). This compound has been a useful tool in the study of mRNA of adenoviruses (10) . It was of obvious interest to see if cordycepin also inhibited replication of RNA tumor viruses. In this communication, cordycepin was used to study the possible role of the poly(A) sequence in virus production induced by 5-iodo-2'-deoxyuridine IdU(11), both from seemingly uninfected murine fibroblasts and from Murine Sarcoma Virus-transformed nonproducing cells. Our results show that cordycepin inhibits induction of viral production by IdU (11, 12) (15, 16) . This is by no-means an absolute criterion (17) the incorporation of IdU into DNA (11), and actinlomycin D caused extensive cell killing (Fig. 3) . However, as will be discussed below, the mechanism of action of cordycepin resembles neither of these two cases.
Effect of Cordycepin, IdU, and Actinomycin D on (Cell Growth.
Since poly(A) synthesis is necessary for normal cell growth (9), inhibition of poly(A) synthesis by cordycepin (9) .would be expected to depress cell growth. In fact, this is the case, as shown in Fig. 3 . Exposure to cordycepin alone or simultaneously with IdU caused a transient depression of cell growth followed by a higher saturation cell-density. This is in contrast to the effect of IdU alone, which caused a long-term effect of a lower saturation cell-density. Such a toxic effect might be caused by incorporation of IdU into DNA and/or by virus production. At the time when maximal virus production occurred (3-4 days after induction), the cell number in an IdU-induced culture was only about 60% that of an uninduced culture, while the cell number in a cordycepin-treated cultured was comparable to that in the IdU-induced culture. Therefore, the transient depression of cell number by cordycepin cannot account for the dramatic inhibition of induction. The effect on cell growth of cordycepin is quite different from that of actinomycin D. Actinomycin D, at a concentration as low as 0.04 jAg/ml, killed almost all of the cells in 2 days (Fig.  3) . It is obvious that the inhibition of induction by cordycepin is not a result of a similar nonspecific cell killing.
To further support the argument that the initial depression of cell growth by cordycepin is not the main cause of the inhibition of induction, an experiment was designed in which cells were treated with cordycepin for 24 hr, after which cordycepin was removed and IdU was added for a further 24 hr. If just a depression of cell growth could cause an inhibition of induction, the culture treated with cordycepin should not be inducible; alternatively, if a specific inhibition of cell growth [such as inhibition of poly(A) synthesis] was required for inhibition of induction, this cordycepin-treated culture should be inducible. The results of this experiment, shown in Table  1 , indicate that the treated culture was inducible. This means that nonspecific depression of cell growth is not the cause of blockage of induction of virus production by cordycepin at the concentration used (100 ,ug/ml) for most experiments.
The last row of this table shows that prior treatment of cells with a low concentration of actinomycin D resulted in so much cell killing that induction of virus production was no longer possible. Again, this result is quite different from the case of treatment with cordycepin.
Naturally Occurring Nucleosides that Contain Adenine Do Not Inhibit Virus Production. In tissue culture, exposure to a sides is toxic to cells. Since cordycepin is an adenine-containing nucleoside, we tested whether this nucleoside-related toxicity was a cause of inhibition of leukovirus induction by cordycepin. The effect of adenosine, 2'-deoxyadenosine, and cyclic AMP, as well as cordycepin, on IdU induction of leukovirus production was studied. Table 2 shows that none of the nucleosides tested, except cordycepin, inhibits the induction of leukovirus production to a significant degree in BALB/3T3 and BALB/K-3T3 cells. The concentration of all compounds was 100 ;zg/ml (about 0.3 mM), which is cytotoxic.
Apparently, cordycepin acts rather specifically to inhibit virus production, and nucleoside-related cytotoxic effect is not a cause of this inhibition.
Cordycepin Acts Only at a Critical Time Interval in the Early Period of Induction. In order to provide more evidence that the inhibition of induction by cordycepin is not due to a toxic effect and, more importantly, to further study the specificity of cordycepin, cordycepin was given at various times during the course of induction and its effect on virus production was measured (Fig. 4) . At each time point, cordycepin was given for 24 hr. The maximum inhibition of induction was obtained only when cordycepin was added simultaneously with IdU. This inhibitory effect decreased when cordycepin was given later than 24 hr after induction. This result suggests that cordycepin works only at an early critical period, which varied from 24 to 48 hr, probably depending on the phase of the cell cycle of the cell populations. The lack of inhibition of virus production by later exposure to cordycepin is additional evidence that cytotoxicity is unlikely as the cause of inhibition of induction.
Since both IdU and cordycepin were present in the medium in the first 24 hr of treatment, cordycepin might simply block the incorporation of IdU into DNA, and cordycepin inhibi- The procedure is the same as Fig. 2 , except that cordycepin was given to the culture for 24 hr at various times during the course of virus induction. The RNA-dependent DNA polymerase activity from the peak of each induced culture was taken for calculation of the percentage of inhibition of induction (see Table 1 ).
infected cells (BALB/3T3) with IdU. This induction procedure provides a relatively simple system to study gene expression of proviral DNA. The fact that cordycepin, an inhibitor of poly(A) synthesis, inhibited the induction of virus production supports the idea that virus production requires a successful transcription of the provirus genome. This successful transcription requires the synthesis and processing of heterogenous RNA, a process in which poly(A) sequences play an important role. To prevent this successful transcription, cordycepin could act either directly to block the poly(A) sequence of unprocessed viral RNA, or indirectly to abort transcription of some messengers whose protein products are required for expression of the proviral genome. Our results do not distinguish between these two alternatives. However, the finding of poly(A) sequence in viral 70S RNA suggests that the former possibility is more likely the case. Furthermore, interpretation of our findings based upon this possibility predicts a post-transcriptional addition of poly(A) to unprocessed viral RNA (10) . In fact, this prediction has been supported by the recent findings of Reitz, Gillespie, and Gallo (unpublished data) that the poly(A) sequence of viral 70S RNA is not copied in a DNA synthesis reaction performed in vitro primed by endogenous viral RNA. This conclusion was based on the lack of the hybridization between poly(A) and the DNA products. If these DNA products do represent the proviruses in cells, the RNA obtained from transcription of the provirus DNA will not contain a poly(A) sequence. For this RNA to obtain a poly(A) sequence, post-transcriptional addition must be required, as in the case of processing of cellular heterogenous RNA. Therefore, our findings, and those of many others, support a model of RNA tumor virus replication via transcription. This model can accommodate both the protovirus hypothesis of Temin (18) and the oncogene hypothesis of Huebner and Todaro (4) .
We also find that cordycepin depresses virus production in some virus-producing cells and that it inhibits focus formation by Murine Sarcoma Virus (manuscript in preparation). cepin is added for the subsequent intervals as indicated.
Proc. Nat. Acad. Sci. USA 69 (1972) Therefore, the above-mentioned mechanism of viral replica-tion may also be applicable to conditions of viral production other than those induced by IdU.
A transient exposure to cordycepin caused a transient depression in cell growth. This finding is different from the irreversible cell killing caused by low concentrations of actinomycin D. However, neither depression of cell growth nor nonspecific cell killing is the cause of cordycepin inhibition of leukovirus production induced by IdU. This inhibition appears to be relatively specific, because of the lack of inhibition by other adenine-containing nucleosides and, more importantly, because of the requirement of a certain critical time early in induction for effective action of cordycepin; however, the mechanism of action of cordycepin on the inhibition of virus production is uncertain. Most likely it acts to block poly(A) synthesis, but general inhibition of RNA synthesis cannot be ruled out, because cordycepin, although it preferentially blocks poly(A) synthesis of nuclear heterogenous RNA, can also inhibit mitochondrial heterogenous RNA synthesis (19, 20) and ribosomal RNA synthesis (20) . Our findings do not bear on the location of the provirus nor the location of its transcription.
